مدیر سایت, نویسنده در موسسه حمایت از بیماران چشمی آرپی

Nine Promising Translational Research Efforts By FFB

FFB-Funded Scientists Report on Nine Promising Translational Research Efforts By Ben Shaberman on July 24, 2017 | 0 Comments Translational research — moving promising science out of laboratories and into clinical trials — is essential to getting vision-saving, retinal-disease treatments...

11 شهریور 1396

Develop a Vision-Restoring System that Connects to the Brain

Training Video

Develop a Vision-Restoring System that Connects to the Brain

Scientists Receive $25 Million to Develop a Vision-Restoring System that Connects to the Brain By Ben Shaberman on July 26, 2017 While researchers around the world are developing numerous drugs and biological therapies for ocular diseases and injuries, an international...

2 شهریور 1396

Training Video

FFB-Casey Innovation

Forty-Four High-Impact Retinal-Research Efforts Highlighted at FFB-Casey Innovation Summit By Ben Shaberman on May 23, 2017 For anyone wanting to know about the latest clinically focused research for inherited retinal diseases (IRDs), the Innovation Summit for Retinal Cell and Gene...

28 مرداد 1396

Training Video

FFB Convenes Experts to Discuss Therapeutic Opportunities for Stargardt Disease

By Ben Shaberman on February 28, 2017 Stargardt disease is the world’s leading cause of inherited macular degeneration, affecting 30,000 people in the United States alone. It is also a challenging condition to understand and treat. While Stargardt disease often...

21 تیر 1396

Training Video

Clock design for the blind

Designed with a smart hour design for the blind and the blind. In the next steps, this technology will be more complete and more information available to the patient … [aparat id=”UqjlG”]

21 تیر 1396

Training Video

First Patient Treated in XLRP Gene Therapy Clinical Trial

By Ben Shaberman on March 20, 2017 A 29-year-old British man is the first person to be treated in a gene therapy clinical trial for X-linked retinitis pigmentosa (XLRP). Robert MacLaren, MD, the lead investigator for the trial taking place...

21 تیر 1396

Training Video

Study for People with USH2A Mutations

By Dr. Steve Rose on April 4, 2017 USH2A is a target for retinal-disease researchers, because mutations in the gene are the most common cause of Usher syndrome type 2, which causes combined vision loss from retinitis pigmentosa (RP) and...

21 تیر 1396

Training Video

jCyte Stem-Cell Therapy Moves into New Phase Clinical for RP

By Ben Shaberman on April 28, 2017 The stem-cell therapy company jCyte is launching a Phase IIb clinical trial of its therapy for people with retinitis pigmentosa (RP). The trial is taking place at University of California, Irvine, and Retina-Vitreous...

21 تیر 1396

Training Video

Dr. Eliot Berson, Pioneer in Vitamin A Therapy for Retinitis Pigmentosa, has died

No one in the retinal disease research community brought more passion and commitment to his or her work than Dr. Eliot Berson. As The William F. Chatlos Professor of Ophthalmology at Harvard Medical School, he dedicated himself to clinical care...

21 تیر 1396